PODESTA GROUP, INC. for EISAI INC.
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Financial Institutions/Investments/Securities FIN
Student Loan Auction Rate Securities (SLARS). H.R. 2017, Continuing Appropriations Act, 2012. H.R. 2608, Continuing Appropriations Act, 2012. S. 365 / Pub. L. 112-25, Budget Control Act of 2011.
Foreign entity interest: Eisai Co., Ltd. to the degree that public policies, either laws or regulations, commercially benefit Eisai, Inc., so too Eisai Co., Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
| THOMAS B SPARKMAN | — |
Medicare/Medicaid MMM
Medicare coverage and reimbursement issues. Monitor debt ceiling negotiations. H.R. 2017, Continuing Appropriations Act, 2012. H.R. 2608, Continuing Appropriations Act, 2012. S. 365 / Pub. L. 112-25, Budget Control Act of 2011. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Foreign entity interest: Eisai Co., Ltd. to the degree that public policies, either laws or regulations, commercially benefit Eisai, Inc., so too Eisai Co., Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
| THOMAS B SPARKMAN | — |
Pharmacy PHA
Drug issues. Prescription Drug User Fee Act reauthorization. FDA-DEA issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation).
Foreign entity interest: Eisai Co., Ltd. to the degree that public policies, either laws or regulations, commercially benefit Eisai, Inc., so too Eisai Co., Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
| THOMAS B SPARKMAN | — |
Copyright/Patent/Trademark CPT
H.R. 1249 / S. 23, America Invents Act.
Foreign entity interest: Eisai Co., Ltd. to the degree that public policies, either laws or regulations, commercially benefit Eisai, Inc., so too Eisai Co., Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
Health Issues HCR
Alzheimer's issues. Patient Protection and Affordable Care Act implementation. Monitor debt ceiling negotiations. Breast cancer efforts. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).
Foreign entity interest: Eisai Co., Ltd. to the degree that public policies, either laws or regulations, commercially benefit Eisai, Inc., so too Eisai Co., Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BRATHWAITE | — |
| SHARON COHEN | — |
| THOMAS B SPARKMAN | — |
Education EDU
Student Loan Auction Rate Securities (SLARS) H.R. 2017, Continuing Appropriations Act, 2012. H.R. 2608, Continuing Appropriations Act, 2012. S. 365 / Pub. L. 112-25, Budget Control Act of 2011.
Foreign entity interest: Eisai Co., Ltd. to the degree that public policies, either laws or regulations, commercially benefit Eisai, Inc., so too Eisai Co., Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
| THOMAS B SPARKMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.